ElevateBio: Detailed Company Information & Corporate Profile
Summary
ElevateBio was founded in 2017 and is headquartered in Waltham, Massachusetts, United States.
The company operates within the pharmaceutical and biotechnology sectors, delivering services that encompass cell therapy, gene therapy, viral vector development, mRNA technology, gene editing, process development, next‑generation sequencing, analytical development, cGMP manufacturing, discovery services, generative AI, and advanced therapies.
With a workforce of 200 to 500 employees, ElevateBio generates annual revenues between $100 million and $500 million. It remains an independent entity that serves clients in the Greater Boston market. Key leaders steering the organization include CEO Christopher Murphy, Vice Presidents Brian Majors (Program Management) and Jeffrey Cram (Process Development), Senior Vice President Mario Miele (Central Engineering Services), and Senior Vice President Aaron Nudelman (Intellectual Property). The leadership team is supported by specialists across talent acquisition, finance, supply chain, business development, human resources, technical operations, and quality control.
| ElevateBio Website | elevate.bio |
| Social Links |   |
| Phone Number | 617-433-2600 |
| Industries | |
| ElevateBio Headquarters Address | 200 Smith St, Waltham, Massachusetts, 02451 US |
| Company Size | 200-500 employees |
| Specialities & Services | cell therapy, gene therapy, , viral vector, mRNA , gene editing, process development , next-generation sequencing, analytical development, cGMP manufacturing, discovery services, generative AI , advanced therapies |
| SIC Code | 2836, 8731 |
| NAICS Code | 325414 Biological Product (except Diagnostic) Manufacturing, 541713 Research and Development in Nanotechnology, 541714 Research and Development in Biotechnology (except Nanobiotechnology), 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| DMA Code | Greater Boston |
| Founded | 2017 |
| Estimated Annual Revenue | $100M - 500M |
| Operating Status | Independent Company |
| Updated: | 2026-09-23 |
ElevateBio Org Chart
Chief Executive Officer
C-Level
Chief Financial Officer
Chief Operating Officer
Chief Commercial Officer
Competitors
Name | Founded | Type | Employees |
|---|---|---|---|
| 2018 | Privately Held | 25 - 100 | |
| 2011 | Privately Held | 100 - 250 | |
| 2017 | Privately Held | 25 - 100 | |
| 2015 | Privately Held | 25 - 100 |
Subsidiaries and Affiliated Companies
Estimated Website Traffic
The chart shows a decline in traffic to the elevate.bio website. In August, traffic decreased to 5262, compared to 5641 in the previous month. The highest traffic in 2026 was recorded in July, reaching 5641 visits.
Workforce Turnover
Number of employees switched from or switched to
Departmental sample breakdown
Length of Employment
ElevateBio's workforce includes employees across a wide range of tenure levels.
4% have been with the company for less than 1 year27% have been with the company for 1 to 2 years15% have been with the company for 3 to 4 years15% have been with the company for 5 to 7 years8% have been with the company for 8 to 10 years31% have been with the company for more than 11 years
Companies Similar to ElevateBio
ElevateBio Corporate Information: FAQ
Data Privacy
GDPR COMPLIANT
SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.
CCPA COMPLIANT
SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.
